28024987|t|Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women
28024987|a|Menopause is associated with increased risk of cardiovascular disease and the causal factors have been proposed to be the loss of estrogen and the subsequent alterations of the hormonal milieu. However, which factors contribute to the deterioration of cardiometabolic health in postmenopausal women is debated as the menopausal transition is also associated with increased age and fat mass. Furthermore, indications of reduced cardiometabolic adaptations to exercise in postmenopausal women add to the adverse health profile. We sought to evaluate risk factors for type 2 diabetes and cardiovascular disease in late premenopausal and early postmenopausal women, matched by age and body composition, and investigate the effect of high-intensity training. A 3-month high-intensity aerobic training intervention, involving healthy, nonobese, late premenopausal (n = 40) and early postmenopausal (n = 39) women was conducted and anthropometrics, body composition, blood pressure, lipid profile, glucose tolerance, and maximal oxygen consumption were determined at baseline and after the intervention. At baseline, the groups matched in anthropometrics and body composition, and only differed by 4.2 years in age (mean [95% confidence limits] 49.2 [48.5-49.9] vs 53.4 [52.4-54.4] years). Time since last menstrual period for the postmenopausal women was (mean [95% confidecnce limits] 3.1 [2.6-3.7] years). Hormonal levels (estrogen, follicle stimulation hormone, luteinizing hormone) confirmed menopausal status. At baseline the postmenopausal women had higher total cholesterol (P < .001), low-density lipoprotein-cholesterol (P < .05), and high-density lipoprotein-cholesterol (P < .001) than the premenopausal women. The training intervention reduced body weight (P < .01), waist circumference (P < .01), and improved body composition by increasing lean body mass (P < .001) and decreasing fat mass (P < .001) similarly in both groups. Moreover, training resulted in lower diastolic blood pressure (P < .05), resting heart rate (P < .001), total cholesterol (P < .01), low-density lipoprotein-cholesterol (P < .01), total cholesterol / high-density lipoprotein-cholesterol index (P < .01), and improved plasma insulin concentration during the oral glucose tolerance test (P < .05) in both groups. Cardiovascular risk factors are similar in late premenopausal and early postmenopausal women, matched by age and body composition, with the exception that postmenopausal women have higher high- and low-density lipoprotein-cholesterol levels. A 3-month intervention of high-intensity aerobic training reduces risk factors for type 2 .diabetes and cardiovascular disease to a similar extent in late premenopausal and early postmenopausal women.
28024987	0	10	Effects of	T080	C1704420
28024987	11	34	high-intensity training	T056	C4277545
28024987	38	65	cardiovascular risk factors	T047	C0850624
28024987	69	82	premenopausal	T033	C0279752
28024987	87	101	postmenopausal	T033	C0232970
28024987	102	107	women	T098	C0043210
28024987	108	117	Menopause	T039	C0025320
28024987	121	136	associated with	T080	C0332281
28024987	137	146	increased	T081	C0205217
28024987	155	177	cardiovascular disease	T047	C0007222
28024987	193	200	factors	T169	C1521761
28024987	230	234	loss	T081	C1517945
28024987	238	246	estrogen	T109,T121,T125	C0014939
28024987	285	300	hormonal milieu	T125	C0019932
28024987	317	324	factors	T169	C1521761
28024987	325	335	contribute	T052	C1880177
28024987	343	356	deterioration	T067	C0868945
28024987	360	382	cardiometabolic health	T042	C0596675
28024987	386	400	postmenopausal	T033	C0232970
28024987	401	406	women	T098	C0043210
28024987	425	435	menopausal	T039	C0025320
28024987	436	446	transition	T052	C2700061
28024987	455	470	associated with	T080	C0332281
28024987	471	480	increased	T081	C0205217
28024987	481	484	age	T032	C0001779
28024987	489	497	fat mass	T032	C3656665
28024987	512	523	indications	T078	C3146298
28024987	527	534	reduced	T080	C0392756
28024987	535	550	cardiometabolic	T042	C0596675
28024987	551	562	adaptations	T038	C0392673
28024987	566	574	exercise	T056	C0015259
28024987	578	592	postmenopausal	T033	C0232970
28024987	593	598	women	T098	C0043210
28024987	610	617	adverse	T046	C0877248
28024987	618	632	health profile	T080	C0018759
28024987	647	655	evaluate	T058	C0220825
28024987	656	668	risk factors	T033	C0035648
28024987	673	688	type 2 diabetes	T047	C0011860
28024987	693	715	cardiovascular disease	T047	C0007222
28024987	719	723	late	T079	C0205087
28024987	724	737	premenopausal	T033	C0279752
28024987	742	747	early	T079	C1279919
28024987	748	762	postmenopausal	T033	C0232970
28024987	763	768	women	T098	C0043210
28024987	781	784	age	T032	C0001779
28024987	789	805	body composition	T032	C0005885
28024987	811	822	investigate	T169	C1292732
28024987	837	860	high-intensity training	T056	C4277545
28024987	872	903	high-intensity aerobic training	T056	C4277545
28024987	904	916	intervention	T061	C0184661
28024987	928	935	healthy	T080	C3898900
28024987	937	945	nonobese	T033	C0243095
28024987	947	951	late	T079	C0205087
28024987	952	965	premenopausal	T033	C0279752
28024987	979	984	early	T079	C1279919
28024987	985	999	postmenopausal	T033	C0232970
28024987	1009	1014	women	T098	C0043210
28024987	1033	1048	anthropometrics	T201	C2598145
28024987	1050	1066	body composition	T032	C0005885
28024987	1068	1082	blood pressure	T040	C0005823
28024987	1084	1097	lipid profile	T059	C0850354
28024987	1099	1116	glucose tolerance	T039	C0178665
28024987	1122	1148	maximal oxygen consumption	T201	C0030055
28024987	1168	1176	baseline	T081	C1442488
28024987	1191	1203	intervention	T061	C0184661
28024987	1208	1216	baseline	T081	C1442488
28024987	1222	1228	groups	T098	C1257890
28024987	1240	1255	anthropometrics	T201	C2598145
28024987	1260	1276	body composition	T032	C0005885
28024987	1312	1315	age	T032	C0001779
28024987	1327	1344	confidence limits	T081	C0237530
28024987	1407	1423	menstrual period	T040	C0025344
28024987	1432	1446	postmenopausal	T033	C0232970
28024987	1447	1452	women	T098	C0043210
28024987	1468	1486	confidecnce limits	T081	C0237530
28024987	1510	1525	Hormonal levels	T034	C1287355
28024987	1527	1535	estrogen	T109,T121,T125	C0014939
28024987	1537	1565	follicle stimulation hormone	T116,T121,T125	C0016774
28024987	1567	1586	luteinizing hormone	T116,T121,T125	C0023607
28024987	1598	1615	menopausal status	T201	C1513126
28024987	1620	1628	baseline	T081	C1442488
28024987	1633	1647	postmenopausal	T033	C0232970
28024987	1648	1653	women	T098	C0043210
28024987	1665	1682	total cholesterol	T109	C0543421
28024987	1695	1730	low-density lipoprotein-cholesterol	T109,T123	C0023824
28024987	1746	1782	high-density lipoprotein-cholesterol	T109,T123	C0023822
28024987	1803	1816	premenopausal	T033	C0279752
28024987	1817	1822	women	T098	C0043210
28024987	1837	1849	intervention	T061	C0184661
28024987	1850	1857	reduced	T080	C0392756
28024987	1858	1869	body weight	T032	C0005910
28024987	1881	1900	waist circumference	T201	C0455829
28024987	1916	1924	improved	T033	C0184511
28024987	1925	1941	body composition	T032	C0005885
28024987	1945	1955	increasing	T169	C0442808
28024987	1956	1970	lean body mass	T201	C0424678
28024987	1986	1996	decreasing	T033	C0442797
28024987	1997	2005	fat mass	T032	C3656665
28024987	2035	2041	groups	T098	C1257890
28024987	2074	2104	lower diastolic blood pressure	T033	C0277890
28024987	2116	2134	resting heart rate	T033	C1821417
28024987	2147	2164	total cholesterol	T109	C0543421
28024987	2176	2211	low-density lipoprotein-cholesterol	T109,T123	C0023824
28024987	2223	2240	total cholesterol	T109	C0543421
28024987	2243	2279	high-density lipoprotein-cholesterol	T109,T123	C0023822
28024987	2301	2309	improved	T033	C0184511
28024987	2310	2338	plasma insulin concentration	T059	C1276042
28024987	2350	2377	oral glucose tolerance test	T060	C0029161
28024987	2396	2402	groups	T098	C1257890
28024987	2404	2431	Cardiovascular risk factors	T047	C0850624
28024987	2447	2451	late	T079	C0205087
28024987	2452	2465	premenopausal	T033	C0279752
28024987	2470	2475	early	T079	C1279919
28024987	2476	2490	postmenopausal	T033	C0232970
28024987	2491	2496	women	T098	C0043210
28024987	2509	2512	age	T032	C0001779
28024987	2517	2533	body composition	T032	C0005885
28024987	2559	2573	postmenopausal	T033	C0232970
28024987	2574	2579	women	T098	C0043210
28024987	2592	2597	high-	T059	C0392885
28024987	2602	2644	low-density lipoprotein-cholesterol levels	T059	C0202117
28024987	2656	2668	intervention	T061	C0184661
28024987	2672	2703	high-intensity aerobic training	T056	C4277545
28024987	2712	2724	risk factors	T033	C0035648
28024987	2729	2745	type 2 .diabetes	T047	C0011860
28024987	2750	2772	cardiovascular disease	T047	C0007222
28024987	2796	2800	late	T079	C0205087
28024987	2801	2814	premenopausal	T033	C0279752
28024987	2819	2824	early	T079	C1279919
28024987	2825	2839	postmenopausal	T033	C0232970
28024987	2840	2845	women	T098	C0043210